BMJ  2007;335:750 (13 October), doi:10.1136/bmj.39316.399931.94

Feature

Head to head

Should young people be given antidepressants? Yes

Pine Lodge Young People's Centre, Cheshire and Wirral Partnership NHS Foundation Trust, Chester CH2 1AW

Depression is disabling a growing proportion of children, but evidence on treatment is disputed. Andrew Cotgrove believes drugs are a vital part of the armoury but Sami Timimi is unconvinced that they are helpful or safe

The first 150 words of the full text of this article appear below.

Depression and obsessive-compulsive disorder cause considerable distress in young people. These disorders affect emotional, educational, and social development. To deny these vulnerable groups the possibility of receiving antidepressants would be to withhold one of the few evidence based treatments available to them.

There are genuine reasons to question their use. Firstly, much of the evidence has, quite rightly, been strongly criticised in recent years. Secondly, the drugs are associated with appreciable risks, in particular an increase in suicidality. Thirdly, other treatments are available. Nevertheless, the evidence indicates that the benefits of these drugs outweigh the risks when used in the appropriate clinical context. I shall focus on the use of selective serotonin reuptake inhibitors (SSRIs) because this is the group of antidepressants for which the evidence in young people is strongest¹ and it is the use of these drugs in depression that has been most controversial.

Quality of evidence

The criticisms of research . . . [Full text of this article]

Risks and benefits

Evidence for other treatments

Obsessive-compulsive disorder

Informed choice

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Should young people be given antidepressants? No

Sami Timimi
BMJ 2007 335: 751. [Extract] [Full Text] [PDF]

Selective serotonin reuptake inhibitors (SSRIs) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: randomised controlled trial

Ian Goodyer, Bernadka Dubicka, Paul Wilkinson, Raphael Kelvin, Chris Roberts, Sarah Byford, Siobhan Breen, Claire Ford, Barbara Barrett, Alison Leech, Justine Rothwell, Lydia White, and Richard Harrington
BMJ 2007 335: 142. [Abstract] [Full Text] [PDF]

Efficacy and safety of antidepressants for children and adolescents

Jon N Jureidini, Christopher J Doecke, Peter R Mansfield, Michelle M Haby, David B Menkes, and Anne L Tonkin
BMJ 2004 328: 879-883. [Extract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

Young people and antidepressants: we need a balanced debate

Anne L. Appleton
bmj.com, 15 Oct 2007 [Full text]

Neurotransmitter Precursors first before SSRI's

Frederick W. Nelson M.S., M.A.
bmj.com, 18 Oct 2007 [Full text]

Benefits and risks of SSRI: a case for shared decision making

Sarah E Hetrick
bmj.com, 19 Oct 2007 [Full text]

Usual care with SSRI treatment

Erin Rogers
bmj.com, 20 Oct 2007 [Full text]